Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)

NCT00267059 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Leukemia

Interventions

DRUG: Lenalidomide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]